Nathan Billings

Nathan has deep expertise in strategy development and early value creation with broad experience in the life sciences. He has spent the past decade identifying and building strategic value for biotech start-ups with disruptive technologies. Prior to Creyon, Nathan served as Director of Intellectual Property at Indigo Agriculture where he joined as employee no. 20 and built de novo a strategic, best-in-class IP portfolio through a Series F round (earning him the nickname the “Patent Ninja”) and unicorn status ($1B+ valuation). The portfolio was leveraged to close a significant IP-backed lending transaction, hedged with an IP insurance product, worth over $100 million, believed to be the largest such transaction ever consummated at the time. Over his career, he has counseled a diverse set of biotech companies and academic institutions and been involved with numerous due diligence assessments for venture capital/private equity financings, competitive intelligence, and freedom to operate analyses, and licensing negotiations. He earned a Ph.D. in Genetics from Harvard University for his work on molecular mechanisms and patterning of early neuronal cell fate decisions. He is registered to practice before the United States Patent and Trademark Office.